|
"tsai cm"的相关文件
显示项目 76-100 / 103 (共5页) << < 1 2 3 4 5 > >> 每页显示[10|25|50]项目
國家衛生研究院 |
2004-07 |
Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
|
Chen, YM; Perng, RP; Chu, H; Tsai, CM; Whang-Peng, J |
國家衛生研究院 |
2004-07 |
Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy
|
Chen, YM;Shih, JF;Tsai, CM;Perng, RP;Whang-Peng, J |
國家衛生研究院 |
2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J |
臺北醫學大學 |
2004 |
Animal study of newly developed injectable gingival reaction material
|
李勝揚; Yang JC; Weng CW; Chen CC; Tsai CM; Lee SY; |
臺北醫學大學 |
2004 |
Dynamic response analysis of the mechanism of mandible trauma.
|
黃豪銘; Lee LY; Huang HM; Huang JM; Chou SY; Lee SY; Chiu WT; Tsai CM; Lo YJ; Lin CT |
中國醫藥大學 |
2004 |
Effect of young barley leaf extract and adlay on plasma lipids and LDL oxidation in hyperlipidemic smokers
|
Yu, YM; Chang, WC; Liu, CS; Tsai, CM |
國家衛生研究院 |
2003-12 |
Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy
|
Chen, YM; Perng, RP; Lee, CS; Lin, WC; Tsai, CM; Whang-Peng, J |
國家衛生研究院 |
2003-05 |
A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older
|
Chen, YM; Perng, RP; Chen, MC; Tsai, CM; Liu, JM; Whang-Peng, J |
中國醫藥大學 |
2003-05 |
LDL cholesterol and oxidation are significantly reduced in type 2 diabetic patients receiving a barley leaf essence supplemented olive oil diet
|
余雅美(Yu YM); (Tsai CM*)* |
國家衛生研究院 |
2003-02 |
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel
|
Chen, YM; Shih, JF; Lee, CS; Chen, MC; Lin, WC; Tsai, CM; Perng, RP |
國家衛生研究院 |
2002-10 |
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
國家衛生研究院 |
2002-10 |
Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
中國醫藥大學 |
2002-02 |
Effect of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes
|
余雅美(Yu YM); 張文正(Chang WC); (Chang CZ); 謝慶良(Ching-Liang Hsieh); (*Tsai CM)* |
國家衛生研究院 |
2002-01 |
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Lee, YC; Shih, JF; Lee, CS; Tsai, CM; Whang-Peng, J |
國家衛生研究院 |
2001-04 |
Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
國家衛生研究院 |
2001-01 |
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
|
Chen, YM; Yang, WK; Whang-Peng, J; Tsai, CM; Perng, RP |
中國醫藥大學 |
2001 |
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer
|
Hsu, NY; Ho, HC; Chow, KC; Lin, TY; Shih, CS; Wang, LS; Tsai, CM |
中國醫藥大學 |
2001 |
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer
|
Hsu, NY; Ho, HC; Chow, KC; Lin, TY; Shih, CS; Wang, LS; Tsai, CM |
國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
國家衛生研究院 |
2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
|
Perng, RP; Shih, JF; Chen, YM; Delgado, FM; Tsai, CM; Chou, KC; Liu, JM; Chern, MS; Whang-Peng, J |
國家衛生研究院 |
2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J |
國家衛生研究院 |
2000-01 |
Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: Interleukin-15 vs. interleukin-2
|
Chen, YM; Ting, CC; Peng, JW; Yang, WK; Yang, KY; Tsai, CM; Perng, RP |
國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
显示项目 76-100 / 103 (共5页) << < 1 2 3 4 5 > >> 每页显示[10|25|50]项目
|